Long read

Scaling green innovation: New IP challenges in the sustainability transition

Corporate abilities to collaborate and share technology across the value chain, including with competitors, and to govern business ecosystems effectively will be key

05 April 2023

Holistic IP strategy layering multiple forms of protection covers innovation at Waymo

In an exclusive interview, IP head Van Nguy reveals her rubric for building a foundational portfolio on emerging tech including a mix of patents, trade secrets and trade dress

22 March 2023

What the UK InterDigital v Lenovo decision means for global SEP licensing disputes

Here’s everything you need to know about last week’s landmark ruling

20 March 2023

A roadmap for industry-academia collaboration to advance IP policy

Ethical and transparent partnerships can help resolve pressing issues all while furthering a company’s goals and interests

08 March 2023

State of inventiveness in Europe

The region is lagging behind its global peers in invention productivity but there are ways this gulf can be crossed

24 February 2023

Patent damages precedent makes waves in component suppliers’ negotiations

After Caltech v Broadcom, suppliers may face higher royalties for infringing components used in downstream products

22 February 2023

Putting diversity initiatives into action: insights from industry-leading IP organisations

In a preview of IAM's upcoming DEI Special Report, those on the cutting edge share experiences of efforts to diversify talent pools, prioritise inclusion and build strong and supportive cultures that yields results

10 February 2023

Patent strategies for protecting bioinformatics inventions

As bioinformatics and computational genomics companies push the boundaries of technology, it is important they overcome subject matter eligibility challenges to protect their innovations

08 February 2023

Neglect begets opportunity in femtech IP

Femtech entrepreneurs can take advantage of large empty spaces on the patent landscape to secure IP protection for their innovations

02 February 2023

Your practical guide to obtaining patent protection for software

Mewburn Ellis' James Leach provides a three-step approach to patenting software inventions

25 January 2023

Key provisions and IP considerations of the incoming EU CHIPS Act

R&D collaboration entails risk and it is therefore vital for companies to start thinking about the best strategies to adopt

11 January 2023

The Leahy legacy: the power of conscience in patent policy

With Senator Leahy due to step down this month, IAM takes a look back at his impact on intellectual property

14 December 2022

Video or it didn’t happen: the video epoch and the coming IP reckoning

Nokia IP Executive Arvin Patel warns that the licensing market is “decidedly thin” and on the cusp of change

07 December 2022

How patent pools have fuelled technology licensing

As Via Licensing marks its 20th anniversary, its journey illustrates the importance of collaborative working – as well as the challenges to overcome

30 November 2022

A ‘brand’ new approach to intellectual asset mapping at Spotify

An updated framework allows for renewed understanding of the way that a broad array of potential brand assets can drive value for knowledge companies

23 November 2022

Your guide to synthetic drug royalty dealmaking

Selling revenue streams is an increasingly important way of monetising pharma innovations

16 November 2022

Here’s how to get attorney fee awards in US patent litigation

A seminal US Supreme Court ruling did not result in a flood of fee awards, but lower courts have hashed out some requirements to secure payment.

09 November 2022

Successfully navigating ‘commercially reasonable effort’ obligations in IP agreements

Tips on winning in the courtroom plus case law and compliance guidance

02 November 2022

Why English litigation will retain a crucial strategic role in the era of the UPC

Though the UK will not be part of the new pan-EU system, it will contain to play a vital role in European litigation

26 October 2022

Exploring third-party claims in pharmaceutical patent cases 

What are the rights of public healthcare providers and companies seeking damages in the United Kingdom, the Netherlands, France and Norway?

19 October 2022

Unlock unlimited access to all IAM content